Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution

Descripción del Articulo

Background: To assess the correlation of WHO histological classification and Masaoka-Koga staging system of thymic epithelial tumors (TETs) with prognosis. Methods: We retrospectively analyzed 83 patients with TETs in the Instituto Nacional de Enfermedades Neoplasicas between 1996 to 2018. We analyz...

Descripción completa

Detalles Bibliográficos
Autores: Rioja, PJ, Ruiz RJ, Galvez-Nino, MJ, Lozano, SJ, Valdiviezo, NJ, Olivera, MJ, Cabero, OJ, Guillen, MEJ, De La Guerra, AJ, Amorin, EJ, Barrionuevo, CJ, Mas, L
Formato: artículo
Fecha de Publicación:2021
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:20.500.14703/102
Enlace del recurso:https: //doi.org/10.1111/1759-7714.13760
https://hdl.handle.net/20.500.14703/102
Nivel de acceso:acceso abierto
Materia:Masaoka-Koga stage
WHO classification
prognostic factors
thymic epithelial tumors
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_c1b135091b870814966dcebaad59d147
oai_identifier_str oai:repositorio.inen.sld.pe:20.500.14703/102
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
spelling PublicationRioja, PJRuiz RJGalvez-Nino, MJLozano, SJValdiviezo, NJOlivera, MJCabero, OJGuillen, MEJDe La Guerra, AJAmorin, EJBarrionuevo, CJMas, L2024-06-13T15:50:48Z2024-06-13T15:50:48Z2021https: //doi.org/10.1111/1759-7714.13760https://hdl.handle.net/20.500.14703/102Thorac CancerBackground: To assess the correlation of WHO histological classification and Masaoka-Koga staging system of thymic epithelial tumors (TETs) with prognosis. Methods: We retrospectively analyzed 83 patients with TETs in the Instituto Nacional de Enfermedades Neoplasicas between 1996 to 2018. We analyzed the clinical stages, histological types and treatment modalities and attempted to determine the impact on overall survival. The data was retrieved from clinical files and reviewed by a pathologist who reclassificated according to the 2004 WHO classification system. The staging was performed with the Masaoka-Koga staging system. Survival curves were constructed with Kaplan-Meir method. Results: There was a total of 83 patients with a median age of 55 years old included in the study. The histological type corresponded to thymoma (T) in 63.8% (n = 53) and to thymic carcinoma (TC) in 36.1%. T were type A, AB, B1, B2 and B3 in 14.4%, 18%, 12%, 3.6%, 7.4% of cases, respectively. The proportion of advanced disease (Masaoka stage III-IV) was high (65%). With a median follow-up of 88.4 months, median overall survival (OS) was 81.6 months for T and 12.3 months for TC (P = 0.01). Univariate analysis showed that sex, histological type, clinical stage and surgery (P = 0.01) were significant independent prognostic factors. On multivariate analysis, histology type and Masaoka-Koga staging had an effect on survival. Conclusions: The results indicates a clear association between the WHO histological classification and Masaoka-Koga staging system with survival. We found a higher proportion of TETs with advanced disease at diagnosis. Further research are required and collaboration is important to foster knowledge focused on classification and treatment.application/pdfengInternational Association for the Study of Lung CancerUSinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/Masaoka-Koga stageWHO classificationprognostic factorsthymic epithelial tumorshttps://purl.org/pe-repo/ocde/ford#3.02.21Epidemiology of thymic epithelial tumors: 22-years experience from a single-institutioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENORIGINALP Rioja 2021.pdfapplication/pdf535176https://repositorio.inen.sld.pe/backend/api/core/bitstreams/e13a67f0-b5c0-4c85-b3b3-a61085d76772/downloadcfce7875a2f3128e1f599e2c9b37e1a0MD51trueAnonymousREADTEXTP Rioja 2021.pdf.txtWritten by FormatFilter org.dspace.app.mediafilter.TikaTextExtractionFilter on 2025-03-29T20:41:34Z (GMT).Extracted texttext/plain27569https://repositorio.inen.sld.pe/backend/api/core/bitstreams/cb661171-7f18-4d2b-aa2c-aeb764e6fdd7/download45029c6da8048d7f4c68d3a9fb9586dbMD54falseAnonymousREADTHUMBNAILP Rioja 2021.pdf.jpgWritten by FormatFilter org.dspace.app.mediafilter.PDFBoxThumbnail on 2025-03-29T20:41:34Z (GMT).Generated Thumbnailimage/jpeg36808https://repositorio.inen.sld.pe/backend/api/core/bitstreams/74f0fcaa-d942-476e-9633-f3ceb095bfe9/downloadcaddb68e3efa8a9f06440735f26465f9MD55falseAnonymousREAD20.500.14703/102oai:repositorio.inen.sld.pe:20.500.14703/1022026-02-15T21:37:23.419Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessopen.accesshttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe
dc.title.none.fl_str_mv Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution
title Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution
spellingShingle Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution
Rioja, PJ
Masaoka-Koga stage
WHO classification
prognostic factors
thymic epithelial tumors
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution
title_full Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution
title_fullStr Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution
title_full_unstemmed Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution
title_sort Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution
author Rioja, PJ
author_facet Rioja, PJ
Ruiz RJ
Galvez-Nino, MJ
Lozano, SJ
Valdiviezo, NJ
Olivera, MJ
Cabero, OJ
Guillen, MEJ
De La Guerra, AJ
Amorin, EJ
Barrionuevo, CJ
Mas, L
author_role author
author2 Ruiz RJ
Galvez-Nino, MJ
Lozano, SJ
Valdiviezo, NJ
Olivera, MJ
Cabero, OJ
Guillen, MEJ
De La Guerra, AJ
Amorin, EJ
Barrionuevo, CJ
Mas, L
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rioja, PJ
Ruiz RJ
Galvez-Nino, MJ
Lozano, SJ
Valdiviezo, NJ
Olivera, MJ
Cabero, OJ
Guillen, MEJ
De La Guerra, AJ
Amorin, EJ
Barrionuevo, CJ
Mas, L
dc.subject.none.fl_str_mv Masaoka-Koga stage
WHO classification
prognostic factors
thymic epithelial tumors
topic Masaoka-Koga stage
WHO classification
prognostic factors
thymic epithelial tumors
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Background: To assess the correlation of WHO histological classification and Masaoka-Koga staging system of thymic epithelial tumors (TETs) with prognosis. Methods: We retrospectively analyzed 83 patients with TETs in the Instituto Nacional de Enfermedades Neoplasicas between 1996 to 2018. We analyzed the clinical stages, histological types and treatment modalities and attempted to determine the impact on overall survival. The data was retrieved from clinical files and reviewed by a pathologist who reclassificated according to the 2004 WHO classification system. The staging was performed with the Masaoka-Koga staging system. Survival curves were constructed with Kaplan-Meir method. Results: There was a total of 83 patients with a median age of 55 years old included in the study. The histological type corresponded to thymoma (T) in 63.8% (n = 53) and to thymic carcinoma (TC) in 36.1%. T were type A, AB, B1, B2 and B3 in 14.4%, 18%, 12%, 3.6%, 7.4% of cases, respectively. The proportion of advanced disease (Masaoka stage III-IV) was high (65%). With a median follow-up of 88.4 months, median overall survival (OS) was 81.6 months for T and 12.3 months for TC (P = 0.01). Univariate analysis showed that sex, histological type, clinical stage and surgery (P = 0.01) were significant independent prognostic factors. On multivariate analysis, histology type and Masaoka-Koga staging had an effect on survival. Conclusions: The results indicates a clear association between the WHO histological classification and Masaoka-Koga staging system with survival. We found a higher proportion of TETs with advanced disease at diagnosis. Further research are required and collaboration is important to foster knowledge focused on classification and treatment.
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2024-06-13T15:50:48Z
dc.date.available.none.fl_str_mv 2024-06-13T15:50:48Z
dc.date.issued.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv https: //doi.org/10.1111/1759-7714.13760
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.14703/102
dc.identifier.journal.none.fl_str_mv Thorac Cancer
url https: //doi.org/10.1111/1759-7714.13760
https://hdl.handle.net/20.500.14703/102
identifier_str_mv Thorac Cancer
dc.language.iso.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv International Association for the Study of Lung Cancer
dc.publisher.country.none.fl_str_mv US
publisher.none.fl_str_mv International Association for the Study of Lung Cancer
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
bitstream.url.fl_str_mv https://repositorio.inen.sld.pe/backend/api/core/bitstreams/e13a67f0-b5c0-4c85-b3b3-a61085d76772/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/cb661171-7f18-4d2b-aa2c-aeb764e6fdd7/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/74f0fcaa-d942-476e-9633-f3ceb095bfe9/download
bitstream.checksum.fl_str_mv cfce7875a2f3128e1f599e2c9b37e1a0
45029c6da8048d7f4c68d3a9fb9586db
caddb68e3efa8a9f06440735f26465f9
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio del Instituto Nacional de Enfermedades Neoplásicas
repository.mail.fl_str_mv repositorio@inen.sld.pe
_version_ 1868438562113847296
score 12.821158
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).